Zusammenfassung
Mehr als 45% aller Todesfälle werden in der Bundesrepublik Deutschland in diesem Jahr kardiovaskulären Ursprungs sein (20). Hauptursachen für diese hohe kardiovaskuläre Mortalität sind koronare Herzerkrankungen und die arterielle Hypertonie (12, 21).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alexander JK, Peterson KL (1972) Cardiovascular effects of weight reduction. Circulation 45: 310–318
Australian National Blood Pressure Study Management Committee (1980). The Australian therapeutic trial in mild hypertension. Lancet 1: 1261–1267
Berry CL (1978) Hypertension and arterial development - Longterm considerations. Br Heart J 40: 709 - 717
Brandt EN Jr (1982) Zitiert in: United States Medicine 18: Heft 1, S 2 und 8 (Januar)
Carey RM, Ayers CR (1976) Labile hypertension — Precursor of sustained hypertension? Am J Med 61: 811–840
Choquette G, Ferguson RJ (1973) Blood pressure reduction in “borderline” hypertensives following physical training. Can Med Assoc J 108: 699–703
Dahl LK (1977) Salt intake and hypertension. In: Hypertension. Genest J, Koiw E, Kuchel O (eds), Mc Graw Hill, New York, p 548–559
Dawber TR (1980) The Framingham Study. The Epidemiology of Atherosclerotic Disease. Harvard Univ. Press, Cambridge (Mass )
Deutsche Liga zur Bekämpfung des hohen Blutdruckes E. V. (1984) Empfehlungen zur Hochdruckbehandlung in der Praxis und zur Behandlung hypertensiver Notfälle. Heidelberg, 5. Auflage, September
Ditschuneit H, Ditschuneit HH, Wechsler J (1979) Adipositasbehandlung — Nulldiät oder kalorienreduzierte Diät? Nulldiät. Internist 20: 151–158
Fisch IR, Frank J (1977) Oral contraceptives and blood pressure. JAMA 237: 2499–2503
Fröhlich ED (1978) Hypertension and angina pectoris. JAMA 239: 344–345
Hany A, Schaub F, Nager F (1965) Die Prognose der behandelten malignen Hypertonie. DMW 90: 18–26
Hedstrand H, Aberg H (1975) A 3-year follow-up of middle-aged men with borderline blood pressure. Acta Med Scand 198: 389–395
Hypertension Detection and Follow-up Program Cooperative Group: Five year findings of the Hypertension Detection and Follow-up Program I. Reduction in mortality of persons with high blood pressure, including mild hypertension (1979). JAMA 242: 2562–2571
Hypertension Detection and Follow-up Programm Cooperative Group: The effect of treatment on mortality in “mild” hypertension. Results of the Hypertension Detection and Follow-up Program (1982). New Engl J Med 307: 976–980
Julius S (1976) Abnormalities of autonomic nervous control in borderline hypertension. Schweiz Med Wochenschr 106: 1698–1705
Julius S (1977) Borderline hypertension. Epidemiologic and clinical implications. In: Genest J, Koiw E, Kuchel O: Hypertension. Mc Graw Hill, New York, p 630–640
Julius S (1978) Clinical and physiological significance of borderline hypertension at youth. Pediatr Clin North Am 25: 35–45
Junge B, Hoffmeister H (1982) Entwicklung von Herzkrankheiten- und Gesamt-Sterblichkeit. Münch Med Wschr 124: 523–529
Kannel WB, Schwartz MJ, McNamara PM (1969) Blood pressure and risk of coronary heart disease: The Framingham Study. Dis Chest 56: 43–52
Kannel WB, Brandt N, Skinner JJ, Dawbler TR, McNamara PM (1967) The relation of adiposity to blood pressure and development of hypertension: The Framingham Study. Ann Intern Med 67: 48–59
Kempner W (1948) Treatment of hypertensive vascular disease with rice diet. Am J Med 4: 545–577
Lew EA (1973) High blood pressure, other risk factors and longevity: The insurance viewpoint. Am J Med 55: 281–294
Linss G, Böthig S (1974) Normotonie oder Hypertonie? Dtsch Gesundh-Wes 29: 635–641
Mc Gregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M (1982) Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet 1: 351–355
Rabkin SW, Mathewson FAL, Hsu PH (1977) Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 years observation period. The Manitoba study. Am J Cardiol 39: 452–458
Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298:–-6
Report of WHO Expert Committee (1978) Arterial hypertension. World Health Organization, Geneva. Technical Report Series 628
Report of Management Committee of the Australian Therapeutic Trial in Mild Hypertension (1982) “untreated mild hypertension”. A Report. The Lancet 1/185–191
Robertson D, Frölich JC, Carr RK, Watson JT, Hollifield JW, Shand DG, Oates JA (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298: 181–186
Rosenman RH, Sholtz RI, Brand RJ (1976) A study of comparative blood pressure measures in predicting risk of coronary heart disease. Circulation 54: 51–58
Simpson FO, Smirk FH (1962) The treatment of malignant hypertension. Am J Cardiol 9: 868–873
Society of Actuaries Committee on Mortality (1960) Build and blood pressure study 1959. Chicago: Society of Actuaries, p 133–176
Sprackling ME, Mitchell JRA, Short AH, Watt G (1981) Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa. Brit Med J 283: 1151–1153
Stamler J, Berkson DM, Dyer A, Lepper MH, Lindberg HA, Oglesby P, McKean H, Rhomberg P, Schoenberger JA, Shekelle RB, Stamler R (1975) Relationship of multiple variables to blood pressure-findings from four Chicago epidemiologic studies. In: Oglesby P (ed) Epidemiology and control of hypertension. G. Thieme, Stuttgart, p 307–356
Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwall M (1981) The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients. N Engl J Med 304: 930–933
U.S. Public Health Service Study Group (McFate Smith W) (1977) Treatment of mild hypertension. Results of ten-year intervention trial. Circ Res 40 (Suppl I) I-98–I105
Veterans Administration Cooperative Study Group on Antihypertensive Agent (1967) Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg. JAMA 202: 1028–1034
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970) Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 213: 1143–1152
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1972) Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease: further analysis of side effects. Circulation 45: 991–1004
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Fassbinder, W. (1986). Arterielle Hypertonie als koronarer und zerebrovaskulärer Risikofaktor. In: Loskot, F. (eds) Herzerkrankungen. Steinkopff. https://doi.org/10.1007/978-3-642-72395-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-72395-7_1
Publisher Name: Steinkopff
Print ISBN: 978-3-642-72396-4
Online ISBN: 978-3-642-72395-7
eBook Packages: Springer Book Archive